[1]
|
Olanow, C.W. and Arendash, G.W. (1994) Metals and free radicals in neurodegeneration. Current Opinion in Neurology, 7, 548-558.
doi:10.1097/00019052-199412000-00013
|
[2]
|
Yasui, M., Kihira, T. and Ota, K. (1992) Calcium, magnesium and alumi-num concentrations in Parkinson’s disease. Neurotoxicology, 13, 593-600.
|
[3]
|
Durlach, J., Bac, P., Durlach, V., Durlach, A., Bara, M. and Guiet-Bara, A. (1997) Are age-related neuro-degenerative diseases linked with various types of magnesium depletion? Magnesium Research, 10, 339-353.
|
[4]
|
Purdey, M. (2004) Elevated levels of ferrimagnetic metals in food chains supporting the Guam cluster of neurodegeneration: Do metal nucleated crystal contaminants [corrected] evoke magnetic fields that initiate the progressive pathogenesis of neurodegeneration? Medical Hypotheses, 63, 793-809. doi:10.1016/j.mehy.2004.04.029.
|
[5]
|
Yasui, M., Ota, K. and Garruto, R.M. (1995) Effects of calcium-deficient diets on manganese deposition in the central nervous system and bones of rats. Neurotoxicology, 16, 511-517.
|
[6]
|
Oyanagi, K., Ka-wakami, E., Kikuchi-Horie, K., Ohara, K., Ogata, K., Takahama, S., Wada, M., Kihira, T. and Yasui, M. (2006) Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Neuropathology, 26, 115-128.
doi:10.1111/j.1440-1789.2006.00672.x
|
[7]
|
Iseri, L.T. and French, J.H. (1984) Magnesium: Nature’s physiologic calcium blocker. American Heart Journal, 108, 188-193. doi:10.1016/0002-8703(84)90572-6
|
[8]
|
Ross, R.T. (1990) Drug-induced parkinsonism and other movement disorders. The Canadian Journal of Neurological Sciences, 17, 155-162.
|
[9]
|
Schmidt, W.J. and Kretschmer, B.D. (1997) Behavioural pharmacology of glutamate receptors in the basal ganglia. Neuroscience and Biobehavioral Reviews, 21, 381-392.
doi:10.1016/S0149-7634(96)00044-9
|
[10]
|
Iuvone, P.M. (1984) Calcium, ATP, and magnesium activate soluble tyrosine hy-droxylase from rat striatum. Journal of Neurochemistry, 43, 1359-1368.
doi:10.1111/j.1471-4159.1984.tb05395.x
|
[11]
|
Hashimoto, T., Nishi, K., Nagasao, J., Tsuji, S. and Oyanagi, K. (2008) Mag-nesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons. Brain Research, 1197, 143-151. doi:10.1016/j.brainres.2007.12.033
|
[12]
|
Nakamura, K., Bindokas, V.P., Marks, J.D., Wright, D.A., Frim, D.M., Miller, R.J. and Kang, U.J. (2000) The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: The role of mitochondrial complex I and reactive oxygen species revisited. Molecular Pharmacology, 58, 271-278.
|
[13]
|
Yasui, M., Yano, I., Yase, Y. and Ota, K. (1991) Distribution of calcium in central nervous system tissue and bones of maintained on calcium-deficient diets. Journal of the Neurological Sciences, 105, 206-210.
doi:10.1016/0022-510X(91)90146-X
|
[14]
|
Garruto, R.M., Shankar, S.K., Yanagihara, R., Salazar, A.M., Amyx, H.L. and Gajdusek, D.C. (1989) Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus monkeys. Acta Neuropathologica, 78, 210-219. doi:10.1007/BF00688211
|
[15]
|
Strong, M.J. (1996) Modeling of acute and chronic aluminum neurotoxicity. In: Yasui, M., Strong, M.J., Ota, K. and Verity, M.A., Eds., Mineral and Metal Neurotoxicology, CRC Press, Boca Raton, 99-106.
|
[16]
|
Komatsu, F., Kagawa, Y., Kawabata, T., Kaneko, Y., Chimedregzen, U., Purvee, B. and Otgon, J. (2011) A high accumulation of hair minerals in Mongolian people: 2(nd) report; influence of manganese, iron, lead, cadmium and aluminum to oxidative stress, Parkinsonism and arthritis. Current Aging Science, 4, 42-56.
doi:10.2174/1874609811104010042
|
[17]
|
Mena, I., Marin, O., Fuenzalida, S. and Cotzias, G.C. (1967) Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology, 17, 128-136.
doi:10.1212/WNL.17.2.128
|
[18]
|
Pentschew, A., Ebner, F.F. and Kovatch, R.M. (1963) Experimental manganese encepha-lopathy in monkeys. A preliminary report. Journal of Neuropathology & Experimental Neurology, 22, 488-499.
doi:10.1097/00005072-196307000-00010
|
[19]
|
Mustafa, S.J. and Chandra, S.V. (1971) Levels of 5-hy- droxytryptamine, dopamine and norepinephrine in whole brain of rabbits in chronic manganese toxicity. Journal of Neurochemistry, 18, 931-933.
doi:10.1111/j.1471-4159.1971.tb12022.x
|
[20]
|
Neff, N.H., Barrett, R.E. and Costa, E. (1969) Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Cellular and Molecular Life Sciences, 25, 1140-1141. doi:10.1007/BF01900234
|
[21]
|
Cotzias, G.C., Papavasiliou, P.S., Ginos, J., Steck, A. and Düby, S. (1971) Metabolic modification of Parkinson’s disease and of chronic manganese poisoning. Annual Review of Medicine, 22, 305-326.
doi:10.1146/annurev.me.22.020171.001513
|
[22]
|
Verity, M.A. (1999) Manganese neurotoxicity: A mecha- nistic hypothesis. Neurotoxicology, 20, 489-497.
|
[23]
|
Nowak, P., Bojanek, K., Szkilnik, R., Jo?ko, J., Boroń, D., Adwent, M., Gorczyca, P., Kostrzewa, R.M. and Brus, R. (2011) Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine. Neuro-toxicity Research, 19, 536-543. doi:10.1007/s12640-010-9184-0
|
[24]
|
Mayer, M.L., Westbrook, G.L. and Guthrie, P.B. (1984) Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature, 309, 261-263.
doi:10.1038/309261a0
|
[25]
|
Schrattenholz, A. and Soskic, V. (2006) NMDA receptors are not alone: Dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to dis-ease-specific nuances of glutamate-signalling. Current Topics in Medicinal Chemistry, 6, 663-686.
doi:10.2174/156802606776894519
|
[26]
|
Lin, J.Y., Chung, S.Y., Lin, M.C. and Cheng, F.C. (2002) Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. Life Science, 71, 803-811.
doi:10.1016/S0024-3205(02)01738-1
|
[27]
|
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. and Prochiantz, A. (1984) Magnesium gates glutamate-activated channels in mouse central neurons. Nature, 307, 462-465. doi:10.1038/307462a0
|
[28]
|
Elliott, P.J., Close, S.P., Walsh, D.M., Hayes, A.G. and Marriott, A.S. (1990) Neuroleptic-induced catalepsy as a model of Parkinson’s disease. II. Effect of glutamate an- tagonists. Journal of Neural Transmission: Parkinson’s Disease and Dementia Section, 2, 91-100.
doi:10.1007/BF02260897
|
[29]
|
Mele, A., Thomas, D.N. and Pert, A. (1997) Different neural mechanisms underlie dizocilpine maleate- and do- pamine agonist-induced locomotor activity. Neuroscience, 82, 43-58. doi:10.1016/S0306-4522(97)00277-7
|
[30]
|
Morelli, M., Fenu, S., Pinna, A. and Di Chiara, G. (1992) Opposite effects of NMDA and AMPA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. The Journal of Pharmacology and Experimental Therapeutics, 260, 402-408.
|
[31]
|
Ossowska, K. (1994) The role of excitatory amino acids in experimental models of Parkinson’s disease. Journal of Neural Transmission: Parkinson’s Disease and Dementia Section, 8, 39-71. doi:10.1007/BF02250917
|